References
Brugières L, Pacquement H, Le Deley MC et al (2009) Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology. J Clin Oncol 27:5056–5061
Kuttesch JF, Krailo MD, Madden T et al (2009) Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies. A Children’s oncology group study. Pediatr Blood Cancer 53:590–593
Subspecialty Group of Hematology, the Society of Pediatrics, Chinese Medical Association, Pediatric Oncology Committee, Chinese Anticancer Association, Editorial Board of Chinese Journal of Pediatrics (2011) Recommendation for pediatric non-Hodgkin’s lymphoma [in Chinese]. Zhonghua Er Ke Za Zhi 49:186–192
Woessmann W, Zimmermann M, Lenhard M, Burkhardt B, Rossig C, Kremens B, Lang P, Attarbaschi A, Mann G, Oschlies I, Klapper W, Reiter A (2011) Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-muenster (BFM)-type first-line therapy: a BFM-group study. J Clin Oncol 29:3065–3071
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yuan, Q., He, Q., Mi, Q. et al. Single-drug vinorelbine as a salvage re-induction regimen for 4 consecutive pediatric patients with relapsed anaplastic large-cell lymphoma in a single children’s institution. Ann Hematol 100, 1093–1095 (2021). https://doi.org/10.1007/s00277-020-04175-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-020-04175-3